Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Targeting inflammatory pathways in hepatocellular carcinoma: recent developments
Research protocols that begin at the target dose without escalation may produce confounding adverse effect data
Researchers have hypothesized that restoring GHK-Cu levels could partially reverse these deficits, though causation has not been established in controlled human trials
In experiments involving mouse models exposed to CS, exposure to GHK-Cu was linked to a potential decrease in the production of pro-inflammatory cytokines, including interleukin-1 (IL-1) and tumor necrosis factor- (TNF-), found in bronchoalveolar lavage fluidfluid used to capture cells and soluble factors from the airways and lung tissues
US$ 28.49
US$ 24.89
US$ 28.67
US$ 23.98
US$ 23.79
